Skip to main content

European Training Network on (+)RNA Virus Replication and Antiviral Drug Development

Objective

Virus infections remain a major cause of disease, with dramatic costs in mortality, morbidity, and economic loss worldwide. There is an unmet need for potent antiviral drugs, in particular against viruses with a (+)RNA genome which include many important pathogens of humans and animals.

Antiviral drug development requires a detailed understanding of virus replication and effective translation of this knowledge into drug discovery. Europe needs well-trained experts with multidisciplinary skills to advance this field. However, few, if any, European training institutes have the broad know-how required to provide such a comprehensive training programme. The EUVIRNA partnership aims to fill this gap with the proposed EUVIRNA training programme.

The EUVIRNA partnership consists of six outstanding European academic partners and four industrial partners (one pharmaceutical R&D company and three SMEs), and an associated partner (SME specialized in education). All EUVIRNA partners are recognized leaders in their field, ensuring state-of-the-art training possibilities, and their skills are highly complementary. Three Visiting Researchers will complement the expertise of the partners.

EUVIRNA aims to introduce 18 ESR’s and 2 ER’s to state-of-the-art knowledge and technology applied in molecular virology and antiviral therapy, with both local and network-wide training activities. Individual research projects, research training workshops and intersectoral secondments will be supplemented with complementary skills courses to improve career development and perspectives. The industrial partners are actively involved in the entire programme, and will furthermore organize a 1-week industry-oriented conference aimed at further bridging the gap between academia and industry.

Thus, EUVIRNA offers talented researchers a multidisciplinary and intersectoral training programme and prepares them for a future leading role in European molecular virology research and antiviral dru

Call for proposal

FP7-PEOPLE-2010-ITN
See other projects for this call

Funding Scheme

MC-ITN - Networks for Initial Training (ITN)

Coordinator

UNIVERSITEIT UTRECHT
Address
Heidelberglaan 8
3584 CS Utrecht
Netherlands
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 789 745
Administrative Contact
Frank Van Kuppeveld (Dr.)

Participants (11)

ACADEMISCH ZIEKENHUIS LEIDEN
Netherlands
EU contribution
€ 615 738
Address
Albinusdreef 2
2333 ZA Leiden
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Marlien Vos (Ms.)
UNIVERSITE D'AIX MARSEILLE
France
EU contribution
€ 496 083
Address
Boulevard Charles Livon 58
13284 Marseille
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Celine Damon (Ms.)
UNIVERSITATSKLINIKUM HEIDELBERG
Germany
EU contribution
€ 454 774
Address
Im Neuenheimer Feld 672
69120 Heidelberg
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Thorsten Brietz (Mr.)
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium
EU contribution
€ 458 069
Address
Oude Markt 13
3000 Leuven
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Myriam Witvrouw (Dr.)
CARDIFF UNIVERSITY
United Kingdom
EU contribution
€ 525 745
Address
Newport Road 30-36
CF24 ODE Cardiff
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Nick Bodycombe (Mr.)
JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA
Belgium
EU contribution
€ 420 089
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Kristien Bonroy (Dr.)
PIKE PHARMA GMBH

Participation ended

Switzerland
EU contribution
€ 123 448
Address
Technoparkstrasse 1
CH-8005 Zuerich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Ulrich Kessler (Dr.)
RIBOXX GMBH
Germany
EU contribution
€ 447 329
Address
Meissner Strasse 191
01445 Radebeul
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Jacques Rohayem (Dr.)
ARATANA THERAPEUTICS NV
Belgium
EU contribution
€ 420 089
Address
Ambachtenlaan 1
3001 Heverlee
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Stefaan Wera (Dr.)
STICHTING RADBOUD UNIVERSITEIT

Participation ended

Netherlands
EU contribution
€ 224 985
Address
Houtlaan 4
6525 XZ Nijmegen
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Wim Van Oijen (Mr.)
UNIVERSITE DE LA MEDITERRANEE D'AIX-MARSEILLE II

Participation ended

France
Address
Boulevard Charles Livon, Jardin Du Pharo 58
13284 Marseille
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Celine Damon (Ms.)